Quanterix QTRX 深 沪
已收盘 08-21 16:00:00 美东时间
2.99
-0.130
-4.17%
华盛通- 最 高3.11
- 今 开3.11
- 成交量 32.32万股
- 最 低 2.99
- 昨 收 3.12
- 总市值 1.41亿
- 52周最高 8.77
- 市盈率 静 --
- 换手率 0.68%
- 52周最低 2.15
- 委 比 19.77%
- 总股本 4729.31万
- 历史最高 92.57
- 量 比 0.37
- 振 幅 3.85%
- 历史最低 2.15
- 每 手 1
- 风险率 1.47%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
TD Cowen Maintains Hold on Quanterix, Lowers Price Target to $3
TD Cowen analyst Dan Brennan maintains Quanterix (NASDAQ:QTRX) with a Hold and lowers the price target from $4 to $3.
08-12 00:05
Quanterix shares are trading lower after the company reported worse-than-expected Q2 financial results.
Quanterix shares are trading lower after the company reported worse-than-expected Q2 financial results.
08-10 21:28
Quanterix misses top-line and bottom-line estimates; updates FY26 outlook
Quanterix press release (QTRX): Q2 GAAP EPS of -$1.04 misses by $0.63. Revenue of $32.91M (+34.4% Y/Y) misses by $4.55M. Revises financial outlook for 2026 and extends date for attaining cash-flow bre...
08-10 20:13
Quanterix Q2 EPS $(1.04) Misses $(0.40) Estimate, Sales $32.906M Miss $37.462M Estimate
Quanterix (NASDAQ:QTRX) reported quarterly losses of $(1.04) per share which missed the analyst consensus estimate of $(0.40) by 160 percent. This is a 121.28 percent decrease over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $32.906 million whi...
08-10 20:03
Quanterix 2026年第二季度财报：营收增长34%，同时下调指引
Quanterix (QTRX) 公布 2026 财年第二季度营收为 3290 万美元，同比增长 34%；同时 GAAP 摊薄每股亏损从 0.77 美元扩大至 1.04 美元。GAAP 毛利率下滑至 38.5%，但调整后 EBITDA 亏损从 1370 万美元收窄至 1000 万美元。一笔与 Akoya 相关的 2690 万美元商誉减值拖累了报告收益。管理层表示，受执行挑战及市场持续疲软影响，公司将 2026 财年营收指引下调至 1.42 亿至 1.48 亿美元，并将预期的现金流盈亏平衡点推迟至 2027 年。截至季度末，公司持有的现金及相关证券为 9690 万美元。
08-10 12:16
Quanterix Q2 2026 earnings: Revenue rises 34% as outlook is cut
Quanterix (QTRX) reported Q2 2026 revenue of $32.9 million, up 34% year over year, while GAAP diluted loss per share widened to $1.04 from $0.77. GAAP gross margin slipped to 38.5%, but the adjusted EBITDA loss narrowed to $10.0 million from $13.7 million. A $26.9 million Akoya-related goodwill impairment weighed on reported earnings. Management cited execution challenges and continued market softness, lowered 2026 revenue guidance to $142 millio
08-10 12:13
Quanterix Q2 Earnings Preview
Quanterix (QTRX) is scheduled to announce Q2 earnings results on Monday, August 10th, before market open. The consensus EPS Estimate is -$0.41 (+46.8% Y/Y) and the consensus Revenue Estimate is $37.46...
08-08 01:09
Quanterix rises on coverage win for Alzheimer’s test
Quanterix Corporation (QTRX) added ~3% in the premarket on Wednesday after announcing that its Alzheimer’s test, LucentAD Complete, will be covered by Elevance Health’s (ELV) Anthem Blue Cross and Blu...
07-15 20:39
